Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Reference223 articles.
1. Andtbacka RH, et al. Talimogene Laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015;33(25):2780–8.
2. Grimaldi AM, Marincola FM, Ascierto PA. Single versus combination immunotherapy drug treatment in melanoma. Expert Opin Biol Ther. 2016;16(4):433–41.
3. Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy in Triple Negative Breast Cancer. Available from: https://clinicaltrials.gov/show/NCT02779855 . Accessed 5 June 2017.
4. Talimogene Laherparepvec and Radiation Therapy in Treating Patients with Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery. Available from: https://clinicaltrials.gov/show/NCT02923778 . Accessed 5 June 2017.
5. A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors. Available from: https://clinicaltrials.gov/show/NCT02819843 . Accessed 5 June 2017.
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献